# Suzhou Baimi Pharmaceutical Technology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/suzhou-baimi-pharmaceutical-technology

- Industry: Pharmaceuticals
- Headquarters: Suzhou, China
- Total disclosed funding: $2.9M
- Latest round: Angel (Aug 20, 2020)
- Investors on record: 2

## About

Based in Suzhou, China and established in 2019, Suzhou Baimi Pharmaceutical Technology is a pharmaceutical company that develops bacteria combine living drugs against immune disease.

The company's business is the development of microbial in vivo drugs. It also develops multi-component bacterial combination in vivo drugs for the treatment of immunomodulation-related diseases, precision intervention in the intestinal flora of patients and precision nutritional provisioning.

## Funding rounds

- Angel, Aug 20, 2020, $2.9M — Yonghua Capital, Bohe Angel Fund

## Investors

- Yonghua Capital (https://capitalatlas.ai/funds/yonghua-capital) — Angel
- Bohe Angel Fund — Angel
